Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Crosstalk between nonalco… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome

Artikel i vetenskaplig tidskrift
Författare S. Lim
M. R. Taskinen
Jan Borén
Publicerad i Obesity Reviews
Volym 20
Nummer/häfte 4
Sidor 599-611
ISSN 1467-7881
Publiceringsår 2019
Publicerad vid Wallenberglaboratoriet
Institutionen för medicin, avdelningen för molekylär och klinisk medicin
Sidor 599-611
Språk en
Länkar dx.doi.org/10.1111/obr.12820
Ämnesord cardiometabolic syndrome, nonalcoholic fatty liver disease, inflammation, oxidative stress, hepatic insulin-resistance, endoplasmic-reticulum stress, c-reactive, protein, term-follow-up, metabolic syndrome, oxidative stress, gut, microbiota, cardiovascular-disease, alanine aminotransferase, risk-factors
Ämneskategorier Klinisk medicin, Endokrinologi

Sammanfattning

Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by fat accumulation combined with low-grade inflammation in the liver. A large body of clinical and experimental data shows that increased flux of free fatty acids from increased visceral adipose tissue and de novo lipogenesis can lead to NAFLD and insulin resistance. Thus, individuals with obesity, insulin resistance, and dyslipidaemia are at the greatest risk of developing NAFLD. Conversely, NAFLD is a phenotype of cardiometabolic syndrome. Notably, researchers have discovered a close association between NAFLD and impaired glucose metabolism and focused on the role of NAFLD in the development of type 2 diabetes. Moreover, recent studies provide substantial evidence for an association between NAFLD and atherosclerosis and cardiometabolic disorders. Even if NAFLD can progress into severe liver disorders including nonalcoholic steatohepatitis (NASH) and cirrhosis, the majority of subjects with NAFLD die from cardiovascular disease eventually. In this review, we propose a potential pathological link between NAFLD/NASH and cardiometabolic syndrome. The potential factors that can play a pivotal role in this link, such as inflammation, insulin resistance, alteration in lipid metabolism, oxidative stress, genetic predisposition, and gut microbiota are discussed.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?